### 38981 Federal Register / Vol. 78, No. 125 / Friday, June 28, 2013 / Notices

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Agency for Healthcare Research and Quality** 

**Notice of Meeting**

**AGENCY :**  Agency for Healthcare Research and Quality, HHS.

**ACTION :**  Notice.

**SUMMARY :**  In accordance with section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), announcement is made of an Agency for Healthcare Research and Quality (AHRQ) Special Emphasis Panel (SEP) meeting on ‘‘LIMITED COMPETITION: ENHANCING INVESTMENTS COMPARATIVE EFFECTIVENESS RESEARCH RESOURCES GRANTS (R01)’’.

**DATES :**  July 23, 2013 (Open on July 23 from 8:30 a.m. to 9:00 a.m. and closed for the remainder of the meeting).

**ADDRESSES :**  Hyatt Regency Hotel Bethesda, One Metro Center, Bethesda, MD 20814.

**FOR FURTHER INFORMATION CONTACT :**  Anyone wishing to obtain a roster ofmembers, agenda or minutes of the nonconfidential portions of this meeting should contact: Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone: (301) 427–

1554.

Agenda items for this meeting are subject to change as priorities dictate.

**SUPPLEMENTARY INFORMATION :**  A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members ofthe Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise.

Substantial segments of the SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for the ‘‘LIMITED COMPETITION: ENHANCING INVESTMENTS COMPARATIVE EFFECTIVENESS RESEARCH RESOURCES GRANTS (R01)’’ are to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Dated: June 13, 2013. Carolyn M. Clancy,

Director.
[FR Doc. 2013–15291 Filed 6–27–13; 8:45 am]

**BILLING CODE 4160–90–M**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Agency for Healthcare Research and Quality** 

**Statement of Organization Functions, and Delegations of Authority** 

Part E, Chapter E (Agency for Healthcare Research and Quality), of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (61 FR 15955–58, April 10, 1996, most recently amended at 73 FR 12737, March 10, 2008) is amended to reflect recent organizational changes, including renaming of the Office of Performance, Accountability, Resources, and Technology to the Office of Management Services to better reflect its functions and the creation of divisions within the office. The specific amendment is as follows:

Under Section E–10, Organization, delete I. Office of Performance, Accountability, Resources, and Technology (EQ) and replace with the following: I. Office of Management Services (EQ)

Under Section E–20. Functions. Delete Office of Performance, Accountability, Resources, and Technology (EQ) and replace with Office of Management Services (EQ). Directs and coordinates the Agency’s administrative services and operational activities. Specifically, the Office provides leadership, oversight, and executive support for human capital management; contracts, grants, and financial management; and administrative services including safety, security, property, space, and facilities management, as well as non-information technology acquisitions. (1) Office of the Director: Leads the design, implementation, and evaluation of management and operational programs that respond to the Agency’s needs. Devises strategies to address Departmental, Office of Personnel Management, and Office of Management and Budget initiatives, including sustainability and the Agency’s conference-approval process, andoversees implementation of Agencywide efforts to address these initiatives. Conducts complex organizational and management analyses and develops major proposals and plans. (2) Division of Administrative Services: Provides oversight and implementation of major administrative programs including the Agency’s ethics program, Continuity of Operations Plans, the Employee Transit Benefit Program, quality of worklife programs, and physical safety and security programs. Manages the Agency’s real property and building relocation and renovation programs, as well as Federal Occupational Health activities. Oversees Public Health Service Commissioned Corps personnel activities and manages Homeland Security Presidential Directive 12 compliance. Provides administrative services including timekeeping, travel, conference and copy center management, mail, and supplies. (3) Division of Contracts Management: Manages all aspects of the Agency’s acquisition program in accordance with Federal acquisition regulations policies, and initiatives. Oversees and implements the Agency’s contract planning, solicitation, review, negotiation, award, post-award administration, payment, and contract closeout activities. Develops, implements, and maintains policies and procedures for the Agency’s acquisition program. Provides guidance to the contracting officer representative community. Manages inter-agency agreements, the purchase card program, and acquisition workforce training and certification programs. (4) Division of Financial Management, Performance, and Evaluation: Provides guidance in all aspects of financial management, including Agency budget formulation and execution, and ensures integration of the budget and planning processes. Manages evaluation and measurement activities for the Agency including development and implementation of the Agency’s annual evaluation plan. Establishes and maintains financial accounting and reporting systems and coordinates responses on budget and accounting matters with all levels of Agency management, Departmental staff, Congressional committees, and the private sector. Serves as the Agency’s focal point for Government Performance and Results Act activities and Program Integrity activities and coordinates the Agency’s efforts for Office of


### 38982 Federal Register / Vol. 78, No. 125 / Friday, June 28, 2013 / Notices

Management and Budget Circular A– 123, Management’s Responsibility for Internal Control. (5) Division of Grants Management: Provides leadership and oversight in grants management and grants management policy to the extramural research community and AHRQ extramural staff through expert guidance, grant analysis and negotiation, outreach, and related information dissemination in order to promote effective stewardship of AHRQ extramural funds in support of healthcare research. (6) Division of Human Capital and Resources Management: Provides guidance to the Agency regarding all aspects of personnel management including staff training, workforce planning and restructuring, and allocation and utilization of human capital resources. Serves as liaison to the Equal Employment Opportunity service provider and to the servicing personnel office to ensure the Agency’s human capital needs, including recruitment, position classification, and compensation, are met and properly executed. Manages the Agency’s human capital reporting function and competitive sourcing activities. Manages the Agency’s awards and performance management program.

These changes are effective upon date of signature.

Dated: June 19, 2013. Carolyn M. Clancy, AHRQ Director.
[FR Doc. 2013–15289 Filed 6–27–13; 8:45 am]

**BILLING CODE 4160–90–M**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Agency for Toxic Substances and Disease Registry** 

**[Docket No. ATSDR–2013–0001]**

**Availability of Draft Toxicological Profiles** 

**AGENCY :**  Agency for Toxic Substances and Disease Registry (ATSDR), Department of Health and Human Services (DHHS).

**ACTION :**  Notice of availability, and request for comments.

**SUMMARY :**  This notice announces the availability of Set 25 Toxicological Profiles for review and comment. Comments can include additional information or reports on studies about the health effects of Set 25 substances. Although ATSDR considered key studies for each of these substances during the profile development process, this Federal Register notice solicits any relevant, additional studies, particularly unpublished data. ATSDR will evaluate the quality and relevance of such data or studies for possible inclusion in the profile. ATSDR remains committed to providing a public comment period for this document as a means to best serve public health and our clients. The Set 25 Toxicological Profile is available online at http://www.atsdr.cdc.gov/ toxprofiles/index.asp and www.regulations.gov, docket ATSDR–
2013–0001.

The Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA), as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA), § 104(i)(3), [42 U.S.C. 9604(i)(3)], directs the ATSDR administrator to prepare toxicological profiles of priority hazardous substances and, as necessary, to revise and publish each updated toxicological profile.

**DATES :**  To be considered, comments on the draft toxicological profiles must be received not later than September 30, 2013. Comments received after close of the public comment period will be considered solely at the discretion of ATSDR, based upon what is deemed to be in the best interest of the general public.

**ADDRESSES :**  You may submit comments, identified by docket number ASTDR– 2013–0001, by any of the following methods:

• Federal eRulemaking Portal: http:// www.reguations.gov. Follow the instructions for submitting comments.

• Mail: Division of Toxicology and Health and Human Sciences, 1600 Clifton Rd. NE., MS F57, Atlanta, GA.
30333.

Instructions: All submissions received must include the agency name and docket number for this notice. All relevant comments will be posted without change. Because all public comments regarding ATSDR toxicological profiles are available for public inspection, no confidential business information or other confidential information should be submitted in response to this notice. Refer to the section Submission of Nominations (below) for specific information required.

**FOR FURTHER INFORMATION CONTACT :**  Ms. Delores Grant, Division of Toxicology and Human Health Sciences, 1600 Clifton Rd. NE., MS F–57, Atlanta, GA 30333. Phone: 770–488–3351. **SUPPLEMENTARY INFORMATION :**  The Superfund Amendments and Reauthorization Act (SARA) (Pub. L. 99–499) amends the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA or Superfund) (42 U.S.C. 9601 et seq. ) by establishing certain responsibilities for ATSDR and the U.S. Environmental Protection Agency (U.S. EPA) with regard to hazardous substances most commonly found at facilities on the CERCLA National Priorities List (NPL). As part of these responsibilities, the ATSDR administrator must prepare toxicological profiles for substances enumerated on the priority list of hazardous substances. This list identifies 275 hazardous substances which, according to ATSDR and U.S. EPA, pose the most significant potential threat to human health. The availability of the revised priority list of 275 hazardous substances was announced in the Federal Register on March 6, 2008 (73 FR 12178). In addition, ATSDR has the authority to prepare toxicological profiles for substances not found at sites on the National Priorities List, in an effort to ‘‘. . . establish and maintain inventory of literature, research, and studies on the health effects of toxic substances’’ under CERCLA Section 104(i)(1)(B). This is also to respond to requests for consultation under section 104(i)(4), and as otherwise necessary to support the site-specific response actions conducted by ATSDR.

Each profile will include an examination, a summary, and an interpretation of available toxicological information and epidemiological evaluations. This information and these data identify the levels of significant human exposure for the substance and for the associated health effects. The profiles must also include a determination of whether adequate information on the health effects of each substance is available or is in the process of development. If adequate information is not available, ATSDR, in cooperation with the National Toxicology Program (NTP), is required to ensure the initiation of a program of research to determine such health effects.

All toxicological profiles issued as ‘‘Drafts for Public Comment’’ represent ATSDR’s best efforts to provide important toxicological information on priority hazardous substances.

Set 25 toxicological profiles: